Search results
30 kwi 2018 · Introduction. As a cause of significant morbidity and mortality, infection with hepatitis E virus (HEV) represents an important global public health problem. The European Association for the Study of Liver (EASL) invited a panel of experts in the field to develop Clinical Practice Guidelines (CPGs) with a particular focus on HEV geno-type (gt) 3.
Hepatitis E is an acute or chronic infection with the hepatitis E virus (HEV). In Europe, most of the infections are locally-acquired and asymptomatic.
20 lip 2023 · Hepatitis E is an inflammation of the liver caused by infection with the hepatitis E virus (HEV). Every year there are an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E.
13 wrz 2024 · Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) [2020] Sub-Saharan Africa. One Health.
Given the paradigm shift in our understanding of zoonotic HEV and that locally acquired HEV is now the commonest cause of acute viral hepatitis in many European countries, the focus of these Clinical Practice Guidelines will be on HEV genotype 3 (and 4).
Over the past decade, dedicated clinical and experimental research has substantiated knowledge on the epidemiology, transmission routes, pathophysiological mechanisms, diagnosis, clinical features and treatment of chronic HEV infection.
Read the EASL Clinical Practice Guideline for the treatment and management of Hepatitis E Virus Infection genotype 3 (and 4).
